In many ways, U.S. health care is the envy of the world—it has helped many individuals live longer than ever and enjoy a better quality of life than previously possible. However, we continue to face the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans.
The Chamber is focused on promoting effective private sector solutions to our health care challenges that will help control costs, expand access, and improve the quality of care.
Opioid abuse and addiction to illegal opioids has become a nation-wide epidemic with a tremendous peril on human lives, the labor participation rate, businesses, and economic growth.
| Our Priorities |
Our goal is to Expand access to and improve the affordability of high-quality health care services for all Americans.
| Our Successes |
This 40% excise tax on employer-sponsored health coverage threatened the value of health benefits for over 180 million Americans. Repeal is projected to save $197 billion over a 10-year period.
The tax on health insurance raised premiums for small businesses, seniors, and millions of others. Repeal is projected to save $150.8 billion over the next decade.
The 2.3% tax on the sale of medical devices hurt the ability of American companies to compete and encouraged businesses to send operations and jobs overseas. Repeal is projected to save $25.5 billion over the next decade.
IRS guidance delineated 14 specific medical care services and items as preventive care when prescribed to treat an individual diagnosed with certain chronic conditions. This delineation enables certain individuals to use Health Savings Account funds to pay for these items before the plan deductible is satisfied, which stands to lower costs for 60% of U.S. adults who have a chronic condition.
Following notice and comment, regulations were revised to remove unnecessary tagline requirements, which is projected to save consumers $3.6 billion over a 5-year period.
Regulations expanded the ability of employers to put aside money on a tax-free basis to help employees purchase health insurance, which provided employees with greater flexibility and choice in selecting their health care coverage.
U.S. Chamber report shows $20 return for a $1 investment in health interventions
This study provides insights into the economic and social returns to investments in prevention and treatment for chronic illnesses across 27 countries. The findings project that countries would on average realize a return of $20 in productivity gains and workers lives saved for every $1 invested in cardiovascular disease and diabetes interventions. Likewise, countries could see a return of $22 for every $1 invested in anxiety disorders and depression interventions.
WASHINGTON, D.C. – U.S. Chamber of Commerce Executive Vice President and Chief Policy Officer Neil Bradley issued the following statement today after the White House issued Executive Orders on drug pricing.
Our VP of Health Policy explains why Congress should strengthen employer-sponsored insurance rather than a create a public option.
Please join us for a discussion with business and policy leaders from across the country on the evolution of the employer-sponsored insurance (ESI) market and the future of this important coverage option for 180 million Americans. During the event we will unveil new research insights into the impact of a public option or Medicare buy-in on employees’ coverage.
Protecting Americans’ Coverage Together (PACT) aims to raise awareness of the perils that a public option or Medicare buy-in will have on the current and future workforce
This paper discusses recent proposals to expand Medicare and lays out the likely impact such a move would have on various stakeholders. For the sake of simplicity, this paper discusses Medicare for all and Medicare buy-in proposals, but the points apply more broadly.
The latest news and updates related to the coronavirus pandemic, tailored specifically for the business community.
WASHINGTON, D.C. – This week the U.S. Chamber of Commerce launched a campaign opposing the Administration’s dangerous new proposal, known as Most Favored Nation pricing, which would impose foreign price controls on American drugs. The campaign asks Americans to tell the White House to reject foreign price controls on drugs and keep American innovation strong.
WASHINGTON, D.C. – U.S. Chamber of Commerce Executive Vice President and Chief Policy Officer Neil Bradley issued the following statement today after the White House issued Executive Orders on drug pricing:
From shipping to staffing, the Chamber and its partners have the tools to save your business money and the solutions to help you run it more efficiently. Join the U.S. Chamber of Commerce today to start saving.
Weekly insights and analysis from the intersection of government and business.
